Sodium Polystyrene Sulfonate and Sorbitol: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Sodium Polystyrene Sulfonate and Sorbitol unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Sodium Polystyrene Sulfonate interacts with Sorbitol

Concomitant sorbitol increases colonic exposure to sodium polystyrene sulfonate, predisposing to intestinal necrosis, particularly in postoperative or uraemic patients.

What you should do

Avoid co-administration with sorbitol-containing formulations; use aqueous suspensions and review the indication for kayexalate in stable hyperkalaemia.

Key facts

Severity

Major — avoid combination

Mechanism

Concomitant sorbitol increases colonic exposure to sodium polystyrene sulfonate, predisposing to intestinal necrosis, pa...

Action

Avoid co-administration with sorbitol-containing formulations; use aqueous suspensions and review the indication for kay...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Sodium Polystyrene Sulfonate and Sorbitol together?

No — this combination should generally be avoided. Avoid co-administration with sorbitol-containing formulations; use aqueous suspensions and review the indication for kayexalate in stable hyperkalaemia.

What is the severity of this interaction?

The interaction between Sodium Polystyrene Sulfonate and Sorbitol is classified as Major — avoid combination. Concomitant sorbitol increases colonic exposure to sodium polystyrene sulfonate, predisposing to intestinal necrosis, particularly in postoperative or uraemic patients.

What should I do if I'm prescribed both?

Avoid co-administration with sorbitol-containing formulations; use aqueous suspensions and review the indication for kayexalate in stable hyperkalaemia. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.